---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-003516"
form_type: "8-K"
ticker: "PMDI"
cik: "0000806517"
company_name: "PSYCHEMEDICS CORP"
filed_at: "2022-05-10T23:59:59+00:00"
generated_at: "2026-06-25T22:06:00.938751+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Psychemedics Q1 revenue up 14% to $6.5M; declares increased dividend of $0.07/share

## Summary
- Revenue $6.5M vs $5.7M (+14% YoY); domestic revenue up 17%, international down 42%.
- Net income $39k ($0.01 diluted EPS) vs $83k; prior year included $800k ERC benefit.
- Declares cash dividend of $0.07/share, payable June 24, 2022, to holders of record May 27, 2022.
- Cash $2.1M, working capital $5.2M; equipment financing $1.1M, repaid $11.1M since May 2014.
- Strategic alternatives review ongoing; CEO cites momentum in oil/gas, transport, and manufacturing.

## SEC filing metadata
- accession: 0001171843-22-003516
- form_type: 8-K
- ticker: PMDI
- cik: 0000806517
- company_name: PSYCHEMEDICS CORP
- filed_at: 2022-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/806517/000117184322003516/0001171843-22-003516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/806517/000117184322003516/f8k_051022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-003516
- JSON: https://secwatch.observer/filing/0001171843-22-003516.json
- Plain text: https://secwatch.observer/filing/0001171843-22-003516.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.